Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection.
10.3350/kjhep.2007.13.3.301
- Author:
Sook Hyang JEONG
1
Author Information
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi, Korea.
- Publication Type:Editorial
- Keywords:
Hepatitis C, chronic;
Treatment outcome;
Genotype;
Pegylated interferon;
Ribavirin
- MeSH:
Antiviral Agents/*administration & dosage/therapeutic use;
Drug Therapy, Combination;
Genotype;
Hepacivirus/genetics;
Hepatitis C, Chronic/*drug therapy;
Humans;
Interferon Alfa-2a/administration & dosage/therapeutic use;
Interferon Alfa-2b/administration & dosage/therapeutic use;
Polyethylene Glycols/administration & dosage/therapeutic use;
Ribavirin/administration & dosage/therapeutic use;
Time Factors;
Treatment Outcome
- From:The Korean Journal of Hepatology
2007;13(3):301-303
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
No abstract available.
